Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Ann Oncol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    January 2018
  1. ROLLIG C, Kramer M, Gabrecht M, Hanel M, et al
    Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicine for acute myeloid leukemia in elderly patients.
    Ann Oncol. 2018 Jan 30. pii: 4829566. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. KHOURY HJ, Gambacorti-Passerini C, Brummendorf TH
    Practical Management of Toxicities Associated With Bosutinib in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia.
    Ann Oncol. 2018 Jan 27. pii: 4827630. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. RAPONI S, Del Giudice I, Marinelli M, Wang J, et al
    Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients.
    Ann Oncol. 2018 Jan 22. pii: 4819111. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  4. HEIDRICH K, Thiede C, Schafer-Eckart K, Schmitz N, et al
    Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations.
    Ann Oncol. 2017 Sep 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  5. MATO AR, Hill BT, Lamanna N, Barr PM, et al
    Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
    Ann Oncol. 2017;28:1050-1056.
    PubMed     Text format     Abstract available


    April 2017
  6. JAIN P, Aoki E, Keating M, Wierda WG, et al
    Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Ann Oncol. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  7. FRIBERG G, Reese D
    Blinatumomab (Blincyto(R)); lessons learned from the bispecific t-cell engager (BiTE(R)) in acute lymphocytic leukemia (ALL).
    Ann Oncol. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. VOSO MT, Leone G, Piciocchi A, Fianchi L, et al
    in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study.
    Ann Oncol. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. BOLIS M, Garattini E, Paroni G, Zanetti A, et al
    Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid.
    Ann Oncol. 2017;28:611-621.
    PubMed     Text format     Abstract available


    February 2017
  10. INABA H, Pei D, Wolf J, Howard SC, et al
    Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
    Ann Oncol. 2017;28:386-392.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: